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Background. ADP-ribosyl cyclases are remarkable enzymes capable of catalyzing multiple reactions including the synthesis of
the novel and potent intracellular calcium mobilizing messengers, cyclic ADP-ribose and NAADP. Not all ADP-ribosyl cyclases
however have been characterized at the molecular level. Moreover, those that have are located predominately at the outer cell
surface and thus away from their cytosolic substrates. Methodology/Principal Findings. Here we report the molecular
cloning of a novel expanded family of ADP-ribosyl cyclases from the sea urchin, an extensively used model organism for the
study of inositol trisphosphate-independent calcium mobilization. We provide evidence that one of the isoforms (SpARC1) is
a soluble protein that is targeted exclusively to the endoplasmic reticulum lumen when heterologously expressed. Catalytic
activity of the recombinant protein was readily demonstrable in crude cell homogenates, even under conditions where luminal
continuity was maintained. Conclusions/Significance. Our data reveal a new intracellular location for ADP-ribosyl cyclases
and suggest that production of calcium mobilizing messengers may be compartmentalized.
Citation: Churamani D, Boulware MJ, Geach TJ, Martin ACR, Moy GW, et al (2007) Molecular Characterization of a Novel Intracellular ADP-Ribosyl
Cyclase. PLoS ONE 2(8): e797. doi:10.1371/journal.pone.0000797
INTRODUCTION
Changes incytosolic Ca
2+ areindispensable for normal cell function
[1]. This is not surprising given the multiple molecular targets for
this ion. In many cells, Ca
2+ elevations result from the mobilization
ofintracellularCa
2+storesbyCa
2+mobilizingmessengersproduced
inresponsetoextracellularcues[1].Inositoltrisphosphateisthebest
characterized of these molecules [1]. In addition, cyclic ADP-ribose
and nicotinic acid adenine dinucleotide phosphate (NAADP), which
were first discovered in the sea urchin egg [2], also play prominent
roles in generating complex Ca
2+ signals [3,4]. Cyclic ADP-ribose
regulates ryanodine receptors on the (sarco)endoplasmic reticulum
to mediate Ca
2+-induced Ca
2+ release [5], whereas NAADP
probablytargetsnovelCa
2+channels[6]locatedonnewlydescribed
acidic Ca
2+ stores [7], although this notion is somewhat controver-
sial [8]. Quite remarkably, both of these messenger molecules are
synthesized in vitro by the same family of enzymes – the ADP-ribosyl
cyclases [9]. These proteins are thus likely to play key roles in Ca
2+–
dependent function.
ADP-ribosyl cyclases have been cloned from Aplysia [10],
mammals [11,12] and more recently Schistosoma [13]. Little is
known concerning the cellular distribution of the Aplysia enzyme
whereas the mammalian homologues, CD38 (a type 2 membrane
protein) and CD157 (a GPI-anchored protein) are both cell surface
antigens with their catalytic sites exposed to the extracellular space
[14]. The Schistosoma enzyme too, appears to be a GPI-anchored
plasma membrane protein [13]. These locations are perplexing
given the cytosolic location of both the substrates for these
enzymes and the Ca
2+ channels targeted by their products. One
attractive hypothesis to explain the apparent ‘‘topology paradox’’
is that cyclic ADP-ribose is produced extracellularly in response to
secreted NAD, followed by its influx into the cell via nucleoside
transporters, including possibly CD38 itself [15]. Alternatively,
CD38 may be internalized upon stimulation [16]. Indeed, in
addition to its plasma membrane distribution, CD38 has been
found in several intracellular locations including the nucleus [17].
Intriguingly, although agonist-evoked cyclic ADP-ribose pro-
duction is abolished in the pancreas of CD38 knockout mice
[18,19], underscoring the importance of CD38 in generating cyclic
ADP-ribose in vivo, basal levels appear unchanged in several tissues
of these animals [20]. These data provide strong evidence for the
existence of CD38-indpendent cyclic ADP-ribose-synthesizing
enzymes. Indeed, novel membrane-associated ADP-ribosyl cyclase
activities have been characterized in the brain of CD38 deficient
mice [21] and other (CD38 replete) cells [22–26]. Moreover, early
studies using sea urchin eggs, described an unusal cyclic GMP-
sensitive ADP-ribosyl cyclase activity located within the cytosol
[27–29]. Cytosolic ADP-ribosyl cyclase activity has also been
characterized in several mammalian tissues [25,30–33], including
the brain [34]. In all of the above cases however, molecular
correlates are lacking. Thus, our molecular understanding of ADP-
ribosyl cyclases is far from complete. This is particularly so in the
sea urchin where many fundamental aspects of the physiology of
both cyclic ADP-ribose and NAADP have been defined in gametes
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several phyla.
Herewe report thefirst molecularcloningofa familyofsea urchin
ADP-ribosyl cyclases. Our data show that one of these isoforms is
a soluble luminal protein located within the endoplasmic reticulum.
We propose compartmentalized production of calcium mobilizing
messengers by this novel ADP-ribosyl cyclase.
RESULTS
Molecular Cloning of a new Family of Sea urchin
ADP-ribosyl Cyclases
ADP-ribosyl cyclase activity was first described in the sea urchin
egg twenty years ago [2] but molecular information regarding
these enzymes in this major model system has not been forth-
coming. Here we report the molecular cloning of three sea urchin
ADP-ribosyl cyclases, we have named SpARC (Strongylocentrotus
purpuratus ADP-ribosyl cyclase) 1–3. All isoforms were cloned by PCR
from ovary and testes cDNA libraries. The putative open reading
frame for SpARC1 corresponded to a 324 amino acid peptide with
a molecular weight of 35 kDa, whereas SpARC2 and SpARC3
were predicted to be longer peptides with molecular weights of
36 kDa and 40 kDa, respectively. Multiple sequence alignments of
SpARCs with each other and other members of the ADP-ribosyl
cyclase family revealed modest sequence similarity at the amino
acid level (Fig. 1A, Table S1). For example, SpARC1 and
SpARC2 are 66% similar whereas their similarity to SpARC3 is
lower at 34 and 36%, respectively (Table S1). Indeed, SpARC1
and SpARC2 appear more similar to Aplysia californica ADP-ribosyl
cyclase and mammalian CD157 (up to 41% similarity) than to
SpARC3 (Table S1). Despite the limited amino acid sequence
homology, there is absolute conservation of a glutamate and two
tryptophan residues shown previously to be crucial for substrate
binding and catalytic activity in other ADP-ribosyl cyclases
(Fig. 1A, green residues) [37]. Moreover, all 10 cysteine residues
found in Aplysia ADP-ribosyl cyclase are also conserved in the sea
urchin homologues (Fig. 1A, yellow residues).
Hydropathy analysis indicated that all three proteins possessed
hydrophobic N and C termini (Fig. S1). The N terminal sequences
were analyzed using the SignalP algorithm [38]. For SpARC1 and
SpARC2, a signal peptide was predicted whereas for SpARC3 the
sequence conformed better to a signal anchor (Table S2). This
analysis is consistent with sea urchin ADP-ribosyl cyclases entering
the secretory pathway. In accord, several consensus sites for
N-glycosylation (N-{P}-[ST]-{P}) are present in all three proteins
(Table S2). We also analyzed the C terminal sequences for
potential GPI anchors using the big PI predictor [39]. High scores
were obtained for both SpARC2 and SpARC3 but not SpARC1
(Table S2). Overall, the architectures of SpARC2 and SpARC3
are similar to CD157 and CD38, respectively whereas SpARC1
appears to represent a novel ADP-ribosyl cyclase. Indeed, the C
terminus of SpARC1 is the most hydrophobic of the isoforms
(Fig. S1) and consistent with the presence of a possible trans-
membrane domain. Because of the potentially unusual nature of
SpARC1, subsequent efforts were focussed on this isoform.
SpARC1 is Glycosylated
For expression studies, we generated a C-terminally myc-tagged
SpARC1 construct. We first performed in vitro transcription/
translation studies using the rabbit reticulocyte system. Given the
Figure 1. A new family of sea urchin ADP-ribosyl cyclases. A, Sequence alignment of the predicted coding regions of three ADP-ribosyl cyclases
isolated from Stronglycentrotus purpuratus cDNA libraries (termed SpARC1-3) and representative members of the ADP-ribosyl cyclase family.
Conserved cysteine and catalytic residues are highlighted in yellow and green, respectively. Abbreviations: Ac, Aplysia californica; Hs, Homo sapiens;
Sm, Schistosoma mansoni.
doi:10.1371/journal.pone.0000797.g001
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reactions were performed with or without acceptor membranes
(Fig. 2A). Autoradiographic analysis of translation reactions
resolved by SDS PAGE, using the reticulocyte lysate alone,
indicated that in vitro-transcribed mRNA drove the expression of
a 46 kDa radiolabeled protein (Fig. 2A). The size of the translated
product was similar to the predicted size of the tagged construct
(47.2 kDa). In the presence of microsomes, slower migrating
protein bands were observed (Fig. 2A, arrows). These data are
consistent with the presence of a signal peptide driving entry of
SpARC1 in to the secretory pathway for its subsequent
glycosylation.
We next expressed myc-tagged SpARC1 in Xenopus laevis because
embryos and oocytes from this model system are extensively used
for the study of secretory pathway proteins [40]. We first analyzed
homogenates prepared from late blastulae that had been injected
at the 2 cell stage with mRNA for myc-tagged SpARC1. Western
blot analysis using an anti-myc antibody revealed the expression of
a 61 kDa protein (Fig. 2B, right). No signal was obtained in un-
injected control embryos (Fig. 2B, left). To determine whether the
increased apparent molecular mass of the expressed construct,
relative to its predicted size (see above), was due to N-
glycosylation, homogenates were treated with PNGase F. Enzyme
treatment reduced the molecular mass of SpARC1 to 46 kDa
(Fig. 2B, right). These data show that SpARC1 is glycosylated.
SpARC1 is a Soluble Luminal Protein
To explore the subcellular distribution of SpARC1, we examined
pellet and supernatant fractions for immunoreactivity following
ultracentrifugation of crude embryo homogenates prepared in the
presence of sucrose (Fig. 3). Consistent with the entry of SpARC1
in to the secretory pathway (see above), SpARC1 immunoreac-
tivity was recovered in pellet fractions and not in the supernatant
containing the cytosol. Somewhat surprisingly however, treatment
of homogenates with Na2CO3, which strips peripheral proteins
and lyses vesicles resulted in near complete solubilisation of
Figure 2. SpARC1 is glycosylated. A, In vitro translation. mRNA coding for C terminally myc-tagged SpARC1 was translated in the presence of
[
35S]methionine using rabbit reticulocyte lysate. Autoradiogram of translation reactions performed in the absence (2) or presence (+) of canine
pancreatic microsomes. B, Expression of SpARC1 in Xenopus laevis embryos. Western blot analysis using an anti-myc antibody of homogenates
prepared from control embryos (C) or embryos injected with mRNA for myc-tagged SpARC1. Samples were either mock treated (2) or digested with
PNGase F (+) prior to analysis (left). Migration of molecular mass markers (in kDa) is shown on the left of the panels.
doi:10.1371/journal.pone.0000797.g002
Figure 3. SpARC1 is a soluble luminal protein. A, Sub-cellular
fractionation. Xenopus laevis embryos expressing myc-tagged SpARC1
were homogenized in a sucrose-containing buffer and diluted in to the
same buffer (C), a carbonate-containing buffer (Na2CO3) or a hypertonic
buffer (Hyper.). In other experiments the embryos were freeze-thawed
and sonicated in a hypotonic buffer (Hypo.). All samples were
centrifuged and the resulting pellets and supernatant fractions analysed
by Western blotting. B, Proteolytic protection. Xenopus laevis embryos
expressing myc-tagged SpARC1 were homogenized in a sucrose-
containing buffer and the homogenates incubated with or without
1% v/v Triton X-100. Samples were then treated with the indicated
concentration of proteinase K before Western blot analysis.
doi:10.1371/journal.pone.0000797.g003
Luminal Messenger Synthesis?
PLoS ONE | www.plosone.org 3 August 2007 | Issue 8 | e797SpARC1 (Fig. 3A). Thus, SpARC1 is unlikely to be an integral
membrane protein and is either peripherally attached to the
membrane or a soluble luminal protein. To distinguish these
possibilities, we took 3 approaches. First, embryos expressing
SpARC1 were freeze-thawed and sonicated in hypotonic medium.
Following this treatment, a substantial fraction of immunoreactiv-
ity translocated to the supernatant fraction (Fig. 3A). These data
suggest that SpARC1 is a soluble luminal protein. Second we
examined the effect of high salt on the distribution of the enzyme.
As shown in Fig. 3A, SpARC1 was largely resistant to the
hypertonic solution and recovered predominantly in the pellet
fraction after treatment (Fig. 3A). This result again supports
a luminal location for SpARC1. Finally, we examined the
susceptibility of SpARC1 to proteolytic attack. Incubation of
homogenates with Proteinase K resulted in the disappearance of
SpARC1 immunoreactivity but only when the homogenates were
pre-treated with detergent (Fig. 3B). These data provide further
evidence that SpARC1 is a soluble vesicular protein.
SpARC1 is not Secreted
Given that SpARC1 enters the secretory pathway (due to its
glycosylation) and is soluble (based on the above fractionation
studies), we next examined whether the protein was secreted. For
these experiments, we expressed SpARC1 in Xenopus laevis oocytes
and examined the medium in which the oocytes were cultured for
immunoreactivity (Fig. 4). Intriguingly, analysis of equivalent
volumes of oocyte homogenates and media did not reveal the
presence of SpARC1 in the latter. These data clearly indicate that
SpARC1 is not a secreted protein. The molecular weight of
SpARC1 (65 kDa) expressed within the oocyte was similar to that
observed in embryos (Figs. 3) consistent with its glycosylation.
SpARC1 Localises to the Endoplasmic Reticulum
To determine the sub-cellular distribution of SpARC1 in more
detail, we localised the expressed protein in oocytes and eggs by
immunocytochemistry (Fig. 5). In these experiments, nuclear
plasmid injections were performed to minimize mis-localisation of
the mRNA. Co-expression of the human reduced folate carrier
tagged with GFP [41], which is a plasma membrane protein,
together with SpARC1, led to cell surface expression of the former
as expected (Fig. 5A). However, SpARC1 immunoreactivity was
broader and distributed deeper into the cell than the tagged
carrier, with peak intensity occurring beneath the oolemma within
the oocyte cortex (Fig. 5A). Higher resolution images of the animal
pole revealed a discrete, reticular pattern of staining in the
expressing oocytes, reminiscent of the cortical endoplasmic
reticulum (Fig. 5B). The observed distribution was specific since
little staining was observed in control un-injected oocytes that were
processed identically (Fig. 5B). In the vegetal pole, SpARC1 was
also expressed in the endoplasmic reticulum, most clearly
evidenced by staining in annulate lamellae, elongated structures
which are endoplasmic reticulum sub-domains [42] (Fig. 5B).
Because the endoplasmic reticulum is known to undergo marked
Figure 4. SpARC1 is not secreted. Control Xenopus laevis oocytes or
oocytes injected with myc-tagged SpARC1 were cultured overnight and
Western blots for both the oocytes (O) and culture media (M)
performed. 0.5 oocyte equivalents were loaded in each lane.
doi:10.1371/journal.pone.0000797.g004
Figure 5. SpARC1 localizes to the endoplasmic reticulum in Xenopus laevis oocytes and eggs. A, Confocal fluorescence images of Xenopus laevis
oocytes co-expressing myc-tagged SpARC1 (red) and GFP-tagged human reduced folate carrier (hRFC, green). SpARC1 expression was detected by
immunocytochemistry using an anti-myc primary antibody and an FITC labeled secondary antibody whereas hRFC was detected by GFP fluorescence.
A plot of the individual emission intensities with depth averaged along a 5 mm wide section (arrowed line) in the overlay image is shown on the right.
B, Lateral (‘xy’) images of SpARC1 expression (green) in oocytes and in eggs (right). The control image was obtained from an identically processed
un-injected oocyte. Images were captured from the animal (A) and vegetal (V) poles as indicated.
doi:10.1371/journal.pone.0000797.g005
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the distribution of SpARC1 in eggs. Consistent with its targeting to
the endoplasmic reticulum, SpARC1 was found in discrete patches
in the vegetal hemisphere of eggs, which are known to be formed
from the endoplasmic reticulum during progesterone-induced
maturation [42]. These data suggest that in stark contrast to other
known ADP-ribosyl cyclases, SpARC1 is an endoplasmic re-
ticulum enzyme.
SpARC1 localisation was further characterised in an indepen-
dent expression system. Western blot analysis of human embryonic
kidney (HEK) cells transfected with SpARC1 identified a 61 kDa
protein the mobility of which was PNGase F-sensitive (Fig. 6A). As
in the oocytes and eggs, SpARC1 was localised to an intracellular
reticular structure (Fig. 6B). There was no appreciable staining in
mock-transfected cells. To identify the organelles to which
SpARC1 was targeted, we co-transfected SpARC1 with fluores-
cent marker proteins for the endoplasmic reticulum and
mitochondria. Immunocytochemical analysis revealed clear colo-
calisation of SpARC1 with DsRed2-ER (Fig. 6B), but not
mitochondrial GFP (Fig. 6C). These data provide further evidence
that SpARC1 is a novel ADP-ribosyl cyclase targeted to the
endoplasmic reticulum.
SpARC1 is Catalytically Active
To determine whether SpARC1 is catalytically active, hypotonic
lysates prepared from Xenopus laevis embryos expressing SpARC1
were examined for base-exchange and cyclization activities.
Incubation of the homogenates with a maximal concentration of
NADP and nicotinic acid at acidic pH resulted in the synthesis of
a product that co-eluted with authentic NAADP (Fig. 7A, solid
trace). These data show that SpARC1 is capable of the base-
exchange reaction. No endogenous activity could be detected from
control un-injected embryos (Fig. 7A, dashed trace). Although the
expression of SpARC1 varied considerably between embryo
batches (Fig. 7B), the initial rate of NAADP production, which
was linear over the first three hours (Fig. 7C), correlated well with
the amount of protein detectable on Western blots (Fig. 7D).
SpARC1-dependent cyclization was also readily demonstrable
in this heterologous expression system. In these experiments, we
used the NAD analogue NGD which when cyclized forms
a metabolically resistant product that is easier to detect than
cyclic ADP-ribose [43]. Incubation of embryo homogenates
expressing SpARC1 with NGD for 21 h, resulted in the synthesis
of a product that coeluted with cyclic-GDP-ribose (Fig. 8A, top).
Modest production was detectable over the first 3 hours (data not
shown) but more readily resolved after more prolonged incuba-
tions as shown. Again, no activity was measurable in control
homogenates (Fig. 8A). These data provide strong evidence that
SpARC1 is a constitutively active, bonafide ADP-ribosyl cyclase.
Luminal SpARC1 can Access its Substrate
Given the normally luminal location of SpARC1, we assayed
homogenates for cyclase activity under conditions that preserved
vesicle architecture. Thus, activity measurements were repeated
using homogenates prepared in the presence of sucrose (see
Fig. 8A, bottom). Remarkably, as summarised in Fig. 8B, cyclic
GDP-ribose production was readily detectable under these
conditions and not different to that observed using hypotonic
lysates prepared from the same embryo batch. These data indicate
that SpARC1 can readily access its substrates despite its
compartmentalisation.
To assess the continuity of the endoplasmic reticulum in our
homogenates, we first examined the distribution of SpARC1 in the
activity assay mixes at the end of the incubations. As shown,
SpARC1 immunoreactivity was confined to the pellet and not
supernatant fractions upon centrifugation (Fig. 8C) providing
evidence that cyclase activity detected was not a result of the
enzyme leaking from the vesicles during the experiments. To
probe the integrity of the endoplasmic reticulum vesicles to smaller
solutes, we incubated the homogenates with
45Ca in the presence
of an ATP regeneration system. Active uptake of the radiolabel
was readily demonstrable and inhibited by the SERCA inhibitor,
thapsigargin (Fig. 8D). Results from three independent experi-
ments indicated that 70613% of the uptake was in to the
endoplasmic reticulum. Similar results were obtained using sea
urchin egg homogenates in which 9563% (n=3) of the
45Ca
uptake was thapsigargin-sensitive (Fig. 8D). These data show that
endoplasmic reticulum vesicles in the embryo homogenates are
sealed and capable of accumulating a small ion. Thus, accessibility
of substrates to SpARC1 is unlikely to result from non-specific
leakiness of the endoplasmic reticulum to small solutes such as
NGD. Furthermore cyclase activity was also detectable following
shorter incubations (3h) where any possible vesicle breach would
be minimal (data not shown).
DISCUSSION
The sea urchin has proved an excellent model for the study of
inositol trisphosphate-independent Ca
2+ mobilization [2,44–47].
ADP-ribosyl cyclase activity was first detected in egg homogenates
leading to the identification of both cyclic ADP-ribose [2,44] and
NAADP [2,45]. Additionally, levels of NAADP were first
measured in sperm [46] and shown to increase at fertilization
[47]. However, despite the undisputed importance of the sea
urchin in the study of both cyclic ADP-ribose- and NAADP-
mediated Ca
2+ signaling - findings quickly extended to other
systems - no molecular details of ADP-ribosyl cyclases have been
available in this major animal model. Here we report for the first
time the molecular cloning of three ADP-ribosyl cyclases from
Strongylocentrotus purpuratus. These findings extend those in mam-
mals where only two ADP-ribosyl cyclases (CD38 and CD157)
have been described at the molecular level, although activity
measurements suggest others [22–32]. Our data then provides the
most comprehensive molecular description of ADP–ribosyl
cyclases in a single organism to date.
A major finding of our study is that SpARC1 localizes to the
endoplasmic reticulum. This is based on our immunocytochemical
analysis of heterologously expressed SpARC1 in eggs and oocytes
of Xenopus laevis and also HEK cells (Figs. 5–6). This location is
entirely consistent with early studies by Lee and colleagues who
identified ADP-ribosyl cyclase activity in a ‘‘light’’ microsomal
fraction in sea urchin eggs [28]. Retention of SpARC1 within the
endoplasmic reticulum is unlikely to be an expression artifact,
because similar results were obtained in two disparate cellular
expression systems. Although highly expressed proteins can
accumulate within the endoplasmic reticulum, this is usually due
to misfolding/aggregation. As we have shown, SpARC1 was
catalytically active and capable of both base-exchange and
cyclization reactions (Figs. 7–8). Indeed, despite modest sequence
similarity between the sea urchin proteins and other ADP-ribosyl
cyclases, critical residues identified in CD38 and ADP-ribosyl
cyclase from Aplysia that dictate structure and function are well
conserved in all of the sea urchin proteins (Fig. 1). These include
cysteine residues and tryptophan 103 (SpARC1 numbering),
which notably is not found in the Schistosoma enzyme [48].
The location of SpARC1 clearly contrasts with that of CD157
and the Schistosoma homologue, which are both GPI-anchored
plasma membrane proteins. CD38, like CD157, is also a cell
Luminal Messenger Synthesis?
PLoS ONE | www.plosone.org 5 August 2007 | Issue 8 | e797Figure 6. SpARC1 localizes to the endoplasmic reticulum in HEK cells. A, Western blot analysis using an anti-myc antibody of homogenates
prepared from mock transfected cells (C) or cells transfected with myc-tagged SpARC1 (left). PNGase F treatment (right) was performed as described
in Fig. 2. B–C, Expression of myc-tagged SpARC1 and DsRed2-ER (B) or mitochondrial GFP (C) in HEK cells transfected with the indicated plasmid or
plasmid combination. SpARC1 expression was detected by immunocytochemistry using an anti-myc primary antibody and a Cy5-labelled secondary
antibody, whereas the endoplasmic reticulum and mitochondria were visualized by fluorescence of the DsRed2 and GFP reporters, respectively.
Results from control, mock-transfected cultures are also shown. Images were captured at the wavelengths corresponding to the colours marked at
the side of the figure.
doi:10.1371/journal.pone.0000797.g006
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organelles [16,17,25] at least in cells of non- hemopoietic origin
[49]. Notably, immunoelectron microscopy reveals the presence of
CD38 within the endoplasmic reticulum of mammalian neurons
[50] consistent with the sub cellular location of SpARC1. Also of
note are reports of unidentified intracellular ADP-ribosyl cyclase
activities in the sarcoplasmic reticulum of several mammalian
muscle types [22–24] again consistent with our findings. Taken
together, these data raise the possibility that localization of ADP-
ribosyl cyclases to the (sarco-) endoplasmic reticulum is unlikely to
be restricted to sea urchins.
Membrane bound ADP-ribosyl cyclase activity has previously
been described in several cell types including sea urchin egg and
sperm homogenates [27–29,46,51], the former preparation
composed predominately of intracellular membranes. Although
hydropathy analysis indicates a potential trans-membrane domain
at the C terminus of SpARC1 (Fig. S1), our experimental data fail
to confirm the prediction. Thus, both Na2CO3 treatment and
hypotonic lysis effect release of SpARC1 from membrane fractions
(Fig. 3A). It is clear from our data that SpARC1 enters the
endoplasmic reticulum based on its sensitivity to PNGase F.
However, because ADP-ribosyl cyclase activity was detectable
even when the continuity of the endoplasmic reticulum was
maintained (Fig. 8), we considered the possibility that this was
a result of translocation of SpARC1 to the cytosolic face of the
membrane. As shown in Fig. 3, SpARC1 was resistant to both
high salt treatment (which would strip peripherally attached
cytosolic proteins) and Proteinase K (which would degrade all
exposed proteins). These data provide strong evidence for
a luminal location. Despite the evidence that SpARC1 is a soluble
endoplasmic reticulum protein, we were unable to detect SpARC1
secretion from Xenopus laevis oocytes overexpressing the enzyme
(Fig. 4). This finding suggests that SpARC1 does not follow the
constitutive secretory pathway. One possibility is that the
hydrophobic C terminal domain is involved in retaining the
enzyme within the endoplasmic reticulum.
Because the binding sites for cyclic ADP-ribose and NAADP on
their respective calcium channels are more than likely cytosolic,
the luminal localization of SpARC1 raises the question of how the
substrates enter and products leave the endoplasmic reticulum. As
shown in Fig. 8A, SpARC1 clearly can gain access to at least one
of its substrates under conditions which preserve luminal
continuity. The integrity of the endoplasmic reticulum was
confirmed by retention of SpARC1 in pellet fractions upon
completion of enzyme assays and the ability of the homogenates to
actively accumulate
45Ca in a thapsigargin-sensitive manner. It is
noteworthy that NAD synthesis occurs largely in the cytoplasm
[52], yet many NAD-requiring enzymes are found in organelles.
Transporters must therefore exist to effect delivery although
r
Figure 7. SpARC1 catalyses NAADP production. A, Hypotonic lysates
from Xenopus laevis embryos were incubated with NADP (1 mM) and
nicotinic acid (NA, 50 mM) at pH 4 for 21 h and the resulting mixtures
separated by HPLC. The top chromatograms are from lysates prepared
from control embryos (dashed lines) and embryos injected with myc-
tagged SpARC1 mRNA (solid line). The elution of authentic NAADP is
shown below. B, Western blot comparing SpARC1 expression in 4
independent embryo preparations. C, Production of NAADP following
incubation of a typical embryo homogenate with substrates for the
indicated times. D, A plot of the initial rate of NAADP production
(measured over 3 h) against the level of SpARC1 expression (de-
termined by densitometric analysis of Western blot data for the
preparations analysed in B).
doi:10.1371/journal.pone.0000797.g007
Luminal Messenger Synthesis?
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first molecular cloning of a mitochondrial NAD transporter [53].
Similar transporters for NAD(P) might therefore be present in the
endoplasmic reticulum (Fig. 9). Luminal targeting of ADP-ribosyl
cyclases could also provide an environment for the accumulation
of necessary co-substrates. For example, although in vitro experi-
ments have established that ADP-ribosyl cyclases can synthesize
NAADP, whether this is the enzymatic route for NAADP synthesis
in vivo is not clear, because of the high millimolar concentrations of
nicotinic acid required to favour the base-exchange reaction (see
[54]). Such concentrations are unlikely to be attained extra-
cellularly, or within the cytosol. However, concentrative uptake in
to a compartment could in principle achieve the necessary
concentrations (Fig. 9). Regarding product release, Deflora and
colleagues have shown that both equilibrative and concentrative
membrane nucleoside transporters can drive uptake of cyclic
ADP-ribose in to cells following its extracellular production [55].
Evidence for a possible NAADP transporter has also been
obtained [56,57]. By analogy, we propose the presence of
topologically similar proteins within the endoplasmic reticulum
to allow release of products to the cytosol (Fig. 9). Indeed,
equilibrative nucleoside transporters have been described in the
nuclear and endoplasmic reticulum membranes [58]. Calcium
mobilizing messenger levels might therefore be regulated by
controlled entry of substrates and/or their release from in-
tracellular compartments. Intriguingly, NAADP-sensitive calcium
channels expressed in sea urchin eggs undergo profound in-
activation to even sub-threshold (pM) concentrations of NAADP
[59,60], yet measured levels of total cellular NAADP appear to be
much higher [46,47]. This finding is entirely consistent with the
compartmentalized synthesis of NAADP.
Calcium signals regulate a whole host of physiological processes
[1]. Cyclic ADP-ribose-mediated calcium signals have been
implicated in key events such as fertilization of sea urchin eggs
[61,62] and insulin secretion from pancreatic beta cells [63].
Calcium signals mediated by NAADP are also important for
Figure 8. SpARC1 catalyses cyclic GDP-ribose production. Homogenates from Xenopus laevis embryos were incubated with 1 mM NGD for 21 h at
pH 7.2 and the resulting mixtures separated by HPLC. A, Representative chromatograms from lysates prepared from control embryos (dashed lines)
and embryos injected with myc-tagged SpARC1 mRNA (solid line). Both hypotonic lysates (Hypo.; top) or homogenates prepared in sucrose-
containing medium (Sucrose; middle) were used. The elution of authentic cyclic GDP-ribose is shown below. B, Pooled data (mean+/2standard error
of the mean) from 3 experiments comparing the amount of cyclic GDP-ribose produced using either control (C) or SpARC1-expressing preparations.
C, Western blot analysis of myc-tagged SpARC1 expression in pellet (P) and supernatant (S) fractions prepared following centrifugation of the two
reaction mixes from a typical experiment described in A at the end of the incubation period. D,
45Ca flux uptake by homogenates prepared from
Xenopus embryos (in sucrose-containing media) or sea urchin eggs either in the absence (2) or presence (+) of the sarco-endoplasmic reticulum
calcium ATPase inhibitor, thapsigargin (Tg; 1 mM). Data are presented as means6standard deviation of triplicate samples from one of 3 independent
experiments.
doi:10.1371/journal.pone.0000797.g008
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neurons such as neurotransmission [65,66], neuronal growth [67]
and differentiation [68]. One prominent feature of all calcium
signals is their complexity with respect to both time and space [1].
For example, calcium changes can be generated in one part of the
cell and have different physiological consequences to those
generated in the other regions [1]. Such complexity is likely key
to maintaining specificity given the multitude of stimuli which use
calcium to mediate their physiological effects. Our data which
suggests that calcium mobilizing messengers may be made within
an organelle provides a novel mechanism by which local calcium
signals could be generated. This is particularly pertinent given that
the endoplasmic reticulum is likely segregated in to functional sub-
domains and can undergo marked re-organization [42,69].
To conclude, molecular identification of sea urchin
ADP-ribosyl cyclases reveals a new location for this family of
enzymes, which may constitute a highly compartmentalized
signaling unit.
MATERIALS AND METHODS
Molecular Cloning of Sea Urchin ADP-Ribosyl
Cyclases
Sea urchin ADP-ribosyl cyclase sequences were determined by
PCR screening of Strongylocentrotus purpuratus cDNA libraries
derived from the testes and/or ovary, the latter kindly provided
by Professor Gary Wessel, Brown University, USA. We used
combinations of vector- and gene-specific primers. Reactions were
initially denatured for 2 min at 94uC followed by 35 cycles of
denaturation (30 s, 94uC), annealing (30 s at the specified
temperature) and extension (3 min, 68uC) using PlatinumH Taq
DNA Polymerase Hi Fidelity (Invitrogen).
A ,1.4 kbp fragment was amplified from the testes library
(annealing temp=56uC) using T7 primer and a forward gene-
specific primer (59-GCAATGTCAAGTGTCGTG-39). The latter
was based upon a 4849 bp contig (contig 638076) identified by an
initial BLAST search of the Stronglylocentrotus purpuratus genome
sequencing project at the Baylor College of Medicine (http://
www.hgsc.bcm.tmc.edu/projects/seaurchin/) with the Aplysia
californica ADP-ribosyl sequence (accession number: P29241).
The amplified product was directly sequenced and found to
correspond to the 39 coding sequence and UTR for a putative
ADP-ribosyl cyclase which we termed SpARC1. The 59 sequence
of the library insert was obtained by PCR using T3 primer and the
following reverse gene-specific primer located in the 39 region of
the putative open reading frame: 59-GGCGTATGGCCCACAG-
TAT-39 (annealing temp=56uC). Sequencing of the 900 bp
amplified product indicated that the insert was a partial 59clone.
A BLAST search of the obtained sequence identified a second
93959 bp contig (contig 638078) that extended the 59 sequence of
SpARC1 to an in frame stop codon.
A search of EST databases with the putative SpARC1 sequence
led to the identification of a larval clone (accession CD306910)
corresponding to the 59 UTR and initial coding sequence of
a second homologue termed SpARC2. PCR using a forward
primer based in the 59 UTR (59-CTGTTTGCATCTAACG-
CACCT-39) and T7 primer (annealing temp=60uC) resulted in
the amplification of a 1.8 kbp product from the ovary library.
Sequencing of this product indicated that it encompassed the
entire open reading frame as evidenced by the presence of two in
frame stop codons.
The sequence of a third homologue (SpARC3) was determined
based on contig 344575 (5103 bp) identified in the initial BLAST
search (see above). A forward gene-specific primer (59-CGTTCA-
CTCGTATGCCAAAG-39)+T3 primer resulted in the amplifica-
tion of an 800 bp product (annealing temp=55uC), the sequence
of which corresponded to the 39 coding region and UTR. The 59
region of the insert was determined by sequencing of a 400 bp
product amplified at an annealing temperature of 55uC using T7
primer and the following reverse gene-specific primer: 59-ACCC-
TTTAGCGAACCCACAT-39. This insert was found to be a
partial 59 clone. A second reverse gene-specific primer (59TTGC-
ATGCTTCACGGTACTT-39) and T7 primer however resulted
in the amplification of a 600 bp product (annealing temp=52uC)
from an independent overlapping insert which extended the 59
sequence to an in frame stop codon. All products were amplified
from the testes library.
A BLAST search of the obtained sequences against the genomic
nucleotide data indicated 97–98% identity (data not shown). One
significant difference was the absence of nucleotides 671–718 of
the SpARC2 sequence from the genome assembly. Our nucleotide
sequence was however confirmed by two recently published ESTs
(accession numbers EC433614 and EC437263). The translational
start site for each isoform was predicted by identifying the first in
frame ATG codon downstream of the 59 stop codon that con-
formed to the Kozak consensus. The predicted coding sequences
have been deposited in GenBank under the following accession
numbers: AM494973 (SpARC1), AM494974 (SpARC2) and
AM494975 (SpARC3).
The full length coding sequence for SpARC1 was amplified at
an annealing temperature of 47uC from the ovary library by PCR
using the following primer pair: SpARC1 1F (59-CACCAGATC-
TATGGGCATCTACACCATATTCA-39)+SpARC1 1R (59-AC-
CCAATCGATCTAGGGTAGTAGATATTGTATTCCAACC-
39). Sites introduced for directional TOPOH cloning (italics) and
restriction enzymes (underlined) are highlighted. The PCR
product was digested with BglII+ClaI and ligated directly in to
pCS2+MT (http://sitemaker.umich.edu/dlturner.vectors/home)
at the BamHI and ClaI sites in order to introduce six myc tags at
the C terminus. The clone was verified by sequencing both strands
of DNA.
Figure 9. Compartmentalized ADP-ribosyl cyclase signalling. Hypo-
thetical scheme whereby putative transporter molecules allow delivery
of substrates from the cytoplasm (Cyto.) to SpARC1 located in the
endoplasmic reticulum (ER) and the subsequent release of the formed
products. See text for details.
doi:10.1371/journal.pone.0000797.g009
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Sequence alignments were performed using Clustal-W [70].
Hydropathy plots were generated using the Kyte-Doolittle
algorithm [71]. Signal peptides/signal anchors and GPI-anchors
were predicted using SignalP version 3.0 [38] and big-PI predictor
[39], respectively. Sequences were scanned for N-glycosylation
sites using the Prosite database on the ExPASy Proteomics Server.
In Vitro Transcription
Capped mRNA transcripts were prepared using the mMessage
mMachineH kit (Ambion) according to the manufacturers instruc-
tions. Briefly, plasmids were linearized at the SacII site, purified on
QIAprep spin columns (Qiagen) and used as templates for SP6-
driven transcription. Reactions were terminated with DNaseI and
the transcripts purified using RNeasy mini spin columns (Qiagen).
In Vitro Translation
mRNA was translated using the rabbit reticulocyte lysate system
either in the absence or presence of canine pancreatic microsomes
(Promega). Typical reactions (25 ml) contained 0.5 mg of mRNA,
17.5 ml of rabbit reticulocyte lysate, 0.5 ml of an amino acid
mixture lacking methionine (1 mM), 1 ml of RNasinH RNase
inhibitor and 29 mCi of
35S -labelled methionine (1000 Ci/mmol;
Pro-mix, G.E Healthcare). Where indicated, 2.4 ml of microsomes
were added. Translation was performed at 30uC for 90 min and
1 ml aliquots of the reactions separated on NuPAGEH 4–12% Bis-
Tris gels (Invitrogen). Autoradiograms were obtained by apposing
the dried gels to BioMax MS film (Kodak) for 2–18 h following
fixation in 40% methanol and 10% acetic acid (20 min).
Cell Culture
Xenopus laevis eggs were procured and fertilized using standard
techniques [40]. Stage VI oocytes were collected from female
Xenopus laevis and maintained in modified Barth’s saline supple-
mented with 25 mg/ml Gentamicin (Sigma). In some experiments,
oocytes were matured in vitro with progesterone (1 mg/ml) for
12 hr incubation at 18uC. Human embryonic kidney (HEK) cells
were maintained in DMEM supplemented with 10% (v/v) serum
and 100 units/ml penicillin and 100 mg/ml streptomycin at 37uC
in a humidified atmosphere of 95% air and 5% CO2. Media was
replaced every 3–4 days.
Microinjection of Xenopus Laevis Embryos and
Oocytes
Embryos were injected at the 2-cell stage with 0.8 ng of synthetic
mRNA per blastomere and incubated in 5% normal amphibian
medium [40], containing 3% Ficoll (Sigma), at 14uC. Embryos were
collected at the late blastula stage. Oocytes were defolliculated by
incubation with 2 mg/ml Collagenase (Sigma Type 1A) in modified
Barth’s saline, for 2 hours with agitation. Following overnight culture
in fresh media at 14uC, healthy oocytes were injected with 20–30 ng
of synthetic capped mRNA. The cells were then maintained for
a further 18–20 h in 96 well plates pre-coated with 1 mg/ml BSA (10
oocytes per well in 50 ml media) before harvesting of cells and media.
For immunolocalisation experiments, cDNA was microinjected
(,8 ng plasmid) directly into the nucleus of the oocyte.
Transfection of HEK Cells
Cells were seeded either directly into 6-well plates (for western
blotting) or onto 25 mm diameter coverslips (for immunocyto-
chemistry). Surfaces were coated with poly-L-lysine (20 mg/ml).
Upon reaching ,90% confluency, the cells were transiently
transfected with 4 mg of pCS2+MT-SpARC1 (see above),
pDsRed2-ER (Invitrogen) or a plasmid encoding for the S65T
mutant of green fluorescent protein targeted to mitochondria
(kindly provided by Prof Rossario Rizzuto, University of Ferrara,
Ferrara, Italy) using Lipofectamine
TM 2000 transfection reagent
(Invitrogen) and according to the manufacturers instructions.
Subsequent immunocytochemistry and western blotting experi-
ments were performed 17 h post-transfection.
Preparation of Cell Homogenates and
Deglycosylation
For embryos and oocytes, the cells were homogenised in a medium
(20 ml/cell) composed of 50 mM NaCl, 10 mM MgAcetate, 1%
v/v Triton X-100, 20 mM Tris (pH 7.2), incubated for 30 min
and then clarified by centrifugation at 21,0006g for 1 min. For
HEK cells, the adherent cells were washed once with phosphate-
buffered saline (10 mM phosphate, 2.7 mM KCl and 137 mM
NaCl, pH 7.4) and homogenized (100 ml/10 cm
2 of confluent
culture) in a medium composed of 150 mM NaCl, 1 mM EDTA,
1% v/v Triton X-100, 20 mM HEPES (pH 7.2). All of the above
procedures were performed at 4uC using homogenization buffers
supplemented with Complete
TM EDTA-free protease inhibitors
(Roche). For deglycosylation, the homogenates (0.5 embryo
equivalents, 25 mg of HEK cell homogenate) were denatured
and treated with PNGase F (New England Biolabs) according to
the manufacturer’s instructions before Western Blot analysis.
Subcellular Fractionation of Xenopus laevis Embryos
Embryos were homogenised in buffer A (20 ml/embryo) composed
of 10% w/v sucrose, 150 mM NaCl, 10 mM MgAcetate and
20 mM Tris (pH 7.2) and diluted two-fold either in to the same
medium, 200 mM Na2CO3 (pH 8.5) or a hypertonic medium
containing 2 M NaCl and 20 mM Tris (pH 7.2). In some
experiments, the embryos were frozen at 220uC, thawed,
homogenized in a hypotonic medium composed of 20 mM
HEPES (pH 7.2) and then sonicated (365 s bursts). All samples
were then incubated for 1 h and centrifuged at 100,0006g for an
additional 1 h. The supernatant fractions were recovered and the
pellets solubilized with a buffer composed of 50 mM NaCl,
10 mM MgAcetate, 1% v/v Triton X-100, 20 mM Tris (pH 7.2)
for 30 min. All procedures were performed at 4uC using buffers
supplemented with Complete
TM protease inhibitors (Roche).
Proteinase K Treatment of Xenopus laevis Embryos
Homogenates from embryos injected with SpARC1 mRNA were
prepared in buffer A as described above except that the protease
inhibitors were omitted. The samples were then diluted two-fold
into the same medium containing a final concentration of
0–50 mg/ml Proteinase K (Sigma) and incubated at 4uC for 1 h.
The protease was then inactivated by the sequential addition of
5 mM PMSF (15 min, 4uC) and pre-warmed SDS PAGE sample
buffer (95uC, 10 min). In control experiments, the homogenates
were first solubilized with 1% v/v Triton X-100 (4uC, 30 min)
before protease treatment.
Western Blotting
Homogenates (0.25–0.5 oocyte/embryo equivalents; 25–50 mgo f
HEK cell homogenate), or oocyte culture medium (0.5–2 oocyte
equivalents) were reduced, separated on NuPAGEH 4–12% Bis-
Tris gels (Invitrogen) and transferred to nitrocellulose filters
(ProBlott
TM, Applied Biosystems) according to standard proce-
dures. The filters were then blocked overnight at 4uC with 5% w/v
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NaCl and 2.7 mM KCl, pH 7.4) containing 0.1% v/v TweenH 20
(TBS-T) and sequentially incubated with anti-c-myc monoclonal
antibody (clone 9e10 from Autogen Bioclear; 1/1000 dilution) and
anti-mouse IgG conjugated to horse-radish peroxidase (1/1000
dilution) in TBS-T supplemented with 2.5% w/v dried skimmed
milk for 1h at room temperature. After each step, the filters were
washed with TBS-T (3630 min). The resulting blots were
developed using the ECL
TM Advanced system (Amersham)
according to the manufacturer’s instructions.
Immunocytochemistry
For oocytes, the cells were fixed by addition of ice cold 1%
formaldehyde in methanol (1 ml/5–10 oocytes) and incubated at
220uC for 2 hrs. The samples were then warmed to room
temperature and incubated with phosphate-buffered saline
supplemented with 0.1% v/v Triton X-100 (PBS-T) for 1 h at
room temperature following sequential washes (5 min) in 75%
methanol/25% PBS-T, 50% methanol/50% PBS-T and 25%
methanol 75% PBS-T. The oocytes were blocked with phosphate-
buffered saline supplemented with 4% w/v bovine serum albumin
for 2–4 h at room temperature and incubated at 4uC overnight
with anti-c-myc monoclonal antibody (myc-tag 9B11 Cell
Signaling Technology 1:1000 dilution) in phosphate-buffered
saline supplemented with 2% w/v bovine serum albumin.
Following a 1 h wash with phosphate-buffered saline (with several
changes of solution), the oocytes were incubated with anti-mouse
IgG conjugated to FITC or rhodamine red (1/200 dilution) for 2 h
at room temperature. The samples were again washed with
phosphate-buffered saline for 1 h and sealed onto glass coverslips
using mounting media (Ted Pella Inc.).
For HEK cells, the cells were fixed in paraformaldehyde (4% w/
v) at 25uC for 10 min and following three washes in phosphate-
buffered saline, permeabilised with Triton X-100 (0.1% v/v,
10 minutes, 25uC). Cells were washed again (three times with
phosphate-buffered saline) and then incubated in blocking buffer
consisting of phosphate-buffered saline supplemented with fetal
bovine serum (5% v/v) and bovine serum albumin (1% w/v) for
1 h at 25uC. Incubation of primary and secondary antibodies
(1/100 dilution) was performed sequentially in blocking buffer at
37uC for 1 h. Unbound antibody was removed after each
incubation by washing the coverslips three times in PBS-T. The
primary antibody used was an anti-c-myc monoclonal antibody
(clone 9e10 from Autogen Bioclear). Antibody binding was
visualised using a secondary antibody (polyclonal, Cy5
TM-
conjugated anti-mouse IgG from goat; Zymed). Coverslips were
mounted onto slides with 1,4-diazabicyclo[2.2.2]octane (DABCO)
and sealed immediately.
Confocal Microscopy
Images of oocytes and eggs were captured using a BioRad
MRC1024 confocal scanner attached to an Olympus AX70
microscope equipped with a 660 oil-immersion objective. Images
of HEK cells were captured using a Zeiss LSM 510 confocal
microscope (Welwyn Garden city, Herts, UK) using conventional
filter-based fluorescence optics. The respective excitation and
emission wavelengths were 488 nm and 505–550 nm for mito-
chondrial GFP, 543 nm and 560–615 nm for DsRed2-ER and
633 nm and .650 nm for Cy5.
Enzyme activity measurements
Xenopus laevis embryos were homogenized (4.5 ul/embryo) in
media containing Complete
TM EDTA-free protease inhibitors
(Roche) and either 20 mM HEPES (pH 7.2) followed by
sonication (365 s bursts) or buffer A. The homogenates prepared
in buffer A were used immediately whereas the hypotonic lysates
were used either immediately or after freezing at 220uC.
For base-exchange activity measurements, hypotonic lysates
(typically 50 ml) were diluted 5-fold in to a medium composed of
1 mM NADP and 50 mM nicotinic acid (pH 4). For measurement
of cyclase activity both hypotonic lysates or homogenates freshly-
prepared in the presence of sucrose (buffer A) were used. In these
experiments, the homogenates were diluted 5-fold in to the same
medium used for their preparation to which 1 mM NGD had
been added. All reactions were allowed to proceed for 3–21 h at
room temperature. At the appropriate time, samples were diluted
10-fold with H2O and particulate material removed by centrifu-
gation (12,0006g, 1 min). The supernatants were analyzed for
nucleotide content by anion exchange HPLC using a 36150 mm
column packed with AGMP1 (Biorad) as described [72] with
minor modification. The column was washed with H2O for 2 min
at a flow rate of 1 ml/min upon injection and bound nucleotides
eluted using a gradient of trifluoroacetic acid that increased
linearly to 2% from 2–8 min, to 4% at 14 min, to 8% at 20 min,
to 16% at 26 min, to 32% at 32 min, to 64% at 38 min and to
100% (150 mM trifluoroacetic acid) at 42 min. Absorbance was
monitored at 254 nm and area measurements of the resolved
peaks determined using Breeze
TM Software (Waters). Elution was
compared to authentic NAADP and cyclic GDP ribose. The latter
was synthesized by incubation of NGD (1 mM) with 2–100 ng/ml
Aplysia ADP-ribosyl cyclase (Sigma) for 1–21 h at room temper-
ature in a buffer containing 20 mM HEPES, pH 7.2.
45Ca flux
Xenopus embryo homogenates were prepared in sucrose-containing
buffer A as described above. The homogenates were then
sequentially diluted (2-fold every 30 minutes, room temperature)
to a final concentration of 22.75 ml/embryo. The dilution buffer
used was buffer A supplemented with 1.5 mM
45CaCl2 (specific
activity=1Ci/mmol; G.E. Healthcare), 3 mg/ml oligomy-
cin+3 mg/ml antimycin (to inhibit mitochondrial uptake) and an
ATP regeneration system composed of 1 mM MgATP, 10 mM
phosphocreatine and 10 U/ml creatine phosphokinase. Incuba-
tions were performed either with or without thapsigargin (1 mM).
After 3 h the samples were quenched by rapid filtration through
Whatman GF-B filters under vacuum followed by three washes
with an ice-cold buffer composed of 300 mM sucrose and 3 mM
EGTA (pH 7.2). Radioactivity associated with the filters was
determined by scintillation counting. Non-specific binding of the
radiolabel was determined in the presence of 10 mM ionomycin.
In parallel experiments, we assayed
45Ca uptake in to sea urchin
egg homogenates (3.125% v/v final) that were prepared as
described previously [73]. Experimental conditions were the same
as those for the Xenopus embryo homogenates except that an
intracellular-like medium composed of 250 mM potassium
gluconate, 250 mM N-methyl-D-glucamine, 1 mM MgCl2 and
20 mM HEPES (pH 7.2, with acetic acid) was used.
SUPPORTING INFORMATION
Figure S1 Hydropathy analysis. Kyte-Doolittle plots of the
amino acid sequences of sea urchin ADP-ribosyl cyclases. A
window size of 19 was used for the analysis.
Found at: doi:10.1371/journal.pone.0000797.g001 (4.54 MB TIF)
Table S1 Amino acid sequence homology between SpARCs and
other members of the ADP-ribosyl cyclase family. Tabulated
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PLoS ONE | www.plosone.org 11 August 2007 | Issue 8 | e797values were calculated from pair-wise alignments. Percentage
identities of the sequences are listed below the diagonal and
percentage similarities above. Abbreviations: Hs, Homo sapiens;
Rn, Rattus norwegicus; Mm, Mus musculus, Oc, Oryctolagus
cuniculus; Cf, Canis familiaris; Bt, Bos taurus; Ac; Aplysia
californica; Ak, Aplysia kurodai; Sm. Schistosoma mansoni.
Found at: doi:10.1371/journal.pone.0000797.g001 (0.06 MB
DOC)
Table S2 Predicted post translation modifications for sea urchin
ADP-ribosyl cyclases. The amino acid sequence for each ADP-
ribosyl cyclase was inspected for the indicated post-translational
modification using the algorithms described in the Methods.
Positive predictions are underlined.
Found at: doi:10.1371/journal.pone.0000797.g001 (0.01 MB
RTF)
ACKNOWLEDGMENTS
We would like to thank Gary Wessel and Rosario Rizzuto for their kind
provision of reagents and to Ian Townley and Kathy Foltz for help with
pilot experiments. Many thanks also to Jez Fabes, Clive Morgan and
Geraint Thomas for advice on molecular techniques, Michael Duchen and
Michelangelo Campanella for assistance with confocal microscopy, Steve
Bolsover for help with image analysis, and Shamshad Cockcroft, Caroline
Dalton and Chi Li for useful discussions.
Author Contributions
Conceived and designed the experiments: VV SP LD DC MB TG YS JM.
Performed the experiments: GM SP LD DC MB TG YS. Analyzed the
data: SP LD DC MB. Contributed reagents/materials/analysis tools: VV
AM. Wrote the paper: SP.
REFERENCES
1. Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of
calcium signalling. Nat Rev Mol Cell Biol 1: 11–21.
2. Clapper DL, Walseth TF, Dargie PJ, Lee HC (1987) Pyridine nucleotide
metabolites stimulate calcium release from sea urchin egg microsomes
desensitized to inositol trisphosphate. J Biol Chem 262: 9561–9568.
3. Lee HC (2004) Multiplicity of Ca2+ messengers and Ca2+ stores: a perspective
from cyclic ADP-ribose and NAADP. Curr Mol Med 4: 227–237.
4. Patel S, Churchill GC, Galione A (2001) Coordination of Ca
2+ signalling by
NAADP. Trends Biochem Sci 26: 482–489.
5. Galione A, Lee HC, Busa WB (1991) Ca(2+)-induced Ca2+ release in sea urchin
egg homogenates: modulation by cyclic ADP-ribose. Science 253: 1143–1146.
6. Berridge G, Dickinson G, Parrington J, Galione A, Patel S (2002) Solubilization
of receptors for the novel Ca
2+-mobilizing messenger, nicotinic acid adenine
dinucleotide phosphate. J Biol Chem 277: 43717–43723.
7. Churchill GC, Okada Y, Thomas JM, Genazzani AA, Patel S, et al. (2002)
NAADP mobilizes Ca
2+ from reserve granules, lysosome-related organelles, in
sea urchin eggs. Cell 111: 703–708.
8. Galione A, Petersen OH (2005) The NAADP Receptor: New Receptors or New
Regulation? Mol Interv 5: 73–79.
9. Lee HC (2000) Enzymatic functions and structures of CD38 and homologs.
Chem Immunol 75: 39–59.
10. Glick DL, Hellmich MR, Beushausen S, Tempst P, Bayley H, et al. (1991)
Primary structure of a molluscan egg-specific NADase, a second-messenger
enzyme. Cell Regul 2: 211–218.
11. Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, et al. (1993)
Formation and hydrolysis of cyclic ADP-Ribose catalysed by lymphocyte antigen
CD38. Science 262: 1056–1059.
12. Hirata Y, Kimura N, Sato K, Oshugi Y, Takasawa S, et al. (1994) ADP-ribosyl
cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1.
FEBS Lett 356: 244–248.
13. Goodrich SP, Muller-Steffner H, Osman A, Moutin MJ, Kusser K, et al. (2005)
Production of Calcium-Mobilizing Metabolites by a Novel Member of the
ADP-Ribosyl Cyclase Family Expressed in Schistosoma mansoni. Biochemistry
44: 11082–11097.
14. Lee HC (2001) Physiological functions of cyclic ADP-ribose and NAADP as
calcium messengers. Annu Rev Pharmacol Toxicol 41: 317–345.
15. De Flora A, Zocchi E, Guida L, Franco L, Bruzzone S (2004) Autocrine and
paracrine calcium signaling by the CD38/NAD+/cyclic ADP-ribose system.
Ann N Y Acad Sci 1028: 176–191.
16. Zocchi E, Franco L, Guida L, Piccini D, Tacchetti C, et al. (1996) NAD+-
dependent internalization of the transmembrane glycoprotein CD38 in human
Namalwa B cells. FEBS Lett 396: 327–332.
17. Adebanjo OA, Anandatheerthavarada HK, Koval AP, Moonga BS, Biswas G,
et al. (1999) A new function for CD38/ADP-ribosyl cyclase in nuclear Ca2+
homeostasis. Nat Cell Biol 1: 409–414.
18. Kato I, Yamamoto Y, Fujimura M, Noguchi N, Takasawa S, et al. (1999) CD38
disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca
2+]i and
insulin secretion. J Biol Chem 274: 1869–1872.
19. Fukushi Y, Kato I, Takasawa S, Sasaki T, Ong BH, et al. (2001) Identification of
cyclic ADP-ribose-dependent mechanisms in pancreatic muscarinic Ca(2+)
signaling using CD38 knockout mice. J Biol Chem 276: 649–655.
20. Partida-Sanchez S, Cockayne DA, Monard S, Jacobson EL, Oppenheimer N, et
al. (2001) Cyclic ADP-ribose production by CD38 regulates intracellular calcium
release, extracellular calcium influx and chemotaxis in neutrophils and is
required for bacterial clearance in vivo. Nat Med 7: 1209–1216.
21. Ceni C, Muller-Steffner H, Lund F, Pochon N, Schweitzer A, et al. (2003)
Evidence for an intracellular ADP-ribosyl cyclase/NAD+-glycohydrolase in
brain from CD38-deficient mice. J Biol Chem 278: 40670–40678.
22. Meszaros LG, Wrenn RW, Varadi G (1997) Sarcoplasmic reticulum-associated
and protein kinase C-regulated ADP-ribosyl cyclase in cardiac muscle. Biochem
Biophys Res Commun 234: 252–256.
23. Wilson HL, Dipp M, Thomas JM, Lad C, Galione A, et al. (2001) ADP-ribosyl
Cyclase and Cyclic ADP-ribose Hydrolase Act as a Redox Sensor. J Biol Chem
276: 11180–11188.
24. Hohenegger M, Suko J, Gscheidlinger R, Drobny H, Zidar A (2002) Nicotinic
acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine
receptor. Biochem J 367: 423–431.
25. Sternfeld L, Krause E, Guse AH, Schulz I (2003) Hormonal control of
ADP-ribosyl cyclase activity in pancreatic acinar cells from rats. J Biol Chem
278: 33629–33636.
26. Xie GH, Rah SY, Kim SJ, Nam TS, Ha KC, et al. (2005) ADP-ribosyl cyclase
couples to cyclic AMP signaling in the cardiomyocytes. Biochem Biophys Res
Commun 330: 1290–1298.
27. Galione A, White A, Willmott N, Turner M, Potter BVL, et al. (1993) cGMP
mobilizes intracellular Ca
2+ in sea urchin eggs by stimulating cyclic ADP-ribose
synthesis. Nature 365: 456–459.
28. Graeff RM, Franco L, De Flora A, Lee HC (1998) Cyclic GMP-dependent and
-independent effects on the synthesis of the calcium messengers cyclic ADP-
ribose and nicotinic acid adenine dinucleotide phosphate. J Biol Chem 273:
118–125.
29. Wilson HL, Galione A (1998) Differential regulation of nicotinic acid-adenine
dinucleotide phosphate and cADP-ribose production by cAMP and cGMP.
Biochem J 331: 837–843.
30. Guse AH, da Silva CP, Berg I, Skapeno AL, Weber K, et al. (1999) Regulation
of calcium signalling in T lymphocytes by the second messenger cyclic ADP-
ribose. Nature 398: 70–73.
31. Bruzzone S, De Flora A, Usai C, Graeff R, Lee HC (2003) Cyclic ADP-ribose is
a second messenger in the lipopolysaccharide-stimulated proliferation of human
peripheral blood mononuclear cells. Biochem J 375: 395–403.
32. Zhang F, Zhang G, Zhang AY, Koeberl MJ, Wallander E, et al. (2006)
Production of NAADP and its role in Ca2+ mobilization associated with
lysosomes in coronary arterial myocytes. Am J Physiol Heart Circ Physiol 291:
H274–H282.
33. Billington RA, Harper C, Bellomo EA, Publicover S, Barratt CL, et al. (2006)
Characterization of cyclic adenine dinucleotide phosphate ribose levels in
human spermatozoa. Fertil Steril 86: 891–898.
34. Matsumura N, Tanuma S (1998) Involvement of cytosolic NAD+ glycohydrolase
in cyclic ADP-ribose metabolism. Biochem Biophys Res Commun 253:
246–252.
35. Lee HC (1996) Cyclic ADP-ribose and calcium signaling in eggs. Biol Signals 5:
101–110.
36. Galione A, Patel S, Churchill GC (2000) NAADP-induced calcium release in sea
urchin eggs. Biol Cell 92: 197–204.
37. Munshi C, Thiel DJ, Mathews II, Aarhus R, Walseth TF, et al. (1999)
Characterization of the active site of ADP-ribosyl cyclase. J Biol Chem 274:
30770–30777.
38. Bendtsen JD, Nielsen H, von HG, Brunak S (2004) Improved prediction of
signal peptides: SignalP 3.0. J Mol Biol 340: 783–795.
39. Eisenhaber B, Bork P, Eisenhaber F (1999) Prediction of potential GPI-
modification sites in proprotein sequences. J Mol Biol 292: 741–758.
40. Sive HL, Grainger RM, Harland RM (2000) Early development of Xenopus laevis:
a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Press.
41. Subramanian VS, Marchant JS, Parker I, Said HM (2001) Intracellular
trafficking/membrane targeting of human reduced folate carrier expressed
in Xenopus oocytes. Am J Physiol Gastrointest Liver Physiol 281:
G1477–G1486.
Luminal Messenger Synthesis?
PLoS ONE | www.plosone.org 12 August 2007 | Issue 8 | e79742. Boulware MJ, Marchant JS (2005) IP3 receptor activity is differentially regulated
in endoplasmic reticulum subdomains during oocyte maturation. Curr Biol 15:
765–770.
43. Graeff RM, Walseth TF, Fryxell K, Branton WD, Lee HC (1994) Enzymatic
synthesis and characterizations of cyclic GDP-ribose. A procedure for
distinguishing enzymes with ADP-ribosyl cyclase activity. J Biol Chem 269:
30260–30267.
44. Lee HC, Walseth TF, Bratt GT, Hayers R, Clapper DL (1989) Structural
determination of a cyclic metabolite of NAD
+ with intracellular Ca
2+-mobilizing
activity. J Biol Chem 264: 1608–1615.
45. Lee HC, Aarhus R (1995) A derivative of NADP mobilizes calcium stores
insensitive to inositol trisphosphate and cyclic ADP-ribose. J Biol Chem 270:
2152–2157.
46. Billington RA, Ho A, Genazzani AA (2002) Nicotinic acid adenine dinucleotide
phosphate (NAADP) is present at micromolar concentrations in sea urchin
spermatozoa. J Physiol 544: 107–112.
47. Churchill GC, O ` Neil JS, Masgrau R, Patel S, Thomas JM, et al. (2003) Sperm
deliver a new messenger:NAADP. Curr Biol 13: 125–128.
48. Kuhn I, Kellenberger E, Rognan D, Lund FE, Muller-Steffner H, et al. (2006)
Redesign of Schistosoma mansoni NAD+ catabolizing enzyme: active site
H103W mutation restores ADP-ribosyl cyclase activity. Biochemistry 45:
11867–11878.
49. Moreno-Garcia ME, Sumoza-Toledo A, Lund FE, Santos-Argumedo L (2005)
Localization of CD38 in murine B lymphocytes to plasma but not intracellular
membranes. Mol Immunol 42: 703–711.
50. Yamada M, Mizuguchi M, Otsuka N, Ikeda K, Takahashi H (1997)
Ultrastructural localization of CD38 immunoreactivity in rat brain. Brain Res
756: 52–60.
51. Chini EN, Thompson MA, Chini CC, Dousa TP (1997) Cyclic ADP-ribose
signaling in sea urchin gametes: metabolism in spermatozoa. Am J Physiol 272:
C416–C420.
52. Berger F, Ramirez-Hernandez MH, Ziegler M (2004) The new life of
a centenarian: signalling functions of NAD(P). Trends Biochem Sci 29: 111–118.
53. Todisco S, Agrimi G, Castegna A, Palmieri F (2006) Identification of the
mitochondrial NAD+ transporter in Saccharomyces cerevisiae. J Biol Chem 281:
1524–1531.
54. Soares S, Thompson M, White T, Isbell A, Yamasaki M, et al. (2006) NAADP as
a second messenger: Neither CD38 nor the base-exchange reaction are
necessary for the in vivo generation of the NAADP in myometrial cells.
Am J Physiol Cell Physiol.
55. Guida L, Bruzzone S, Sturla L, Franco L, Zocchi E, et al. (2002) Equilibrative
and concentrative nucleoside transporters mediate influx of extracellular cyclic
ADP-ribose into 3T3 murine fibroblasts. J Biol Chem 277: 47097–47105.
56. Heidemann AC, Schipke CG, Kettenmann H (2005) Extracellular application of
nicotinic acid adenine dinucleotide phosphate induces Ca2+ signaling in
astrocytes in situ. J Biol Chem 280: 35630–35640.
57. Billington RA, Bellomo EA, Floriddia EM, Erriquez J, Distasi C, et al. (2006) A
transport mechanism for NAADP in a rat basophilic cell line. FASEB J 20:
521–523.
58. Mani RS, Hammond JR, Marjan JM, Graham KA, Young JD, et al. (1998)
Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in
nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by
functional reconstitution in proteoliposomes. J Biol Chem 273: 30818–30825.
59. Aarhus R, Dickey DM, Graeff R, Gee KR, Walseth TF, et al. (1996) Activation
and inactivation of Ca
2+ release by NAADP
+. J Biol Chem 271: 8513–8516.
60. Genazzani AA, Empson RM, Galione A (1996) Unique inactivation properties
of NAADP-sensitive Ca
2+ release. J Biol Chem 271: 11599–11602.
61. Galione A, McDougall A, Busa WB, Willmott N, Gillot I, et al. (1993)
Redundant mechanisms of calcium-induced calcium release underlying calcium
waves during fertilization of sea urchin eggs. Science 261: 348–352.
62. Lee HC, Aarhus R, Walseth TF (1993) Calcium mobilization by dual receptors
during fertilization of sea urchin eggs. Science 261: 352–355.
63. Takasawa S, Nata K, Yonekura H, Okamoto H (1993) Cyclic ADP-ribose in
insulin secretion from pancreatic beta cells. Science 259: 370–373.
64. Lim D, Kyozuka K, Gragnaniello G, Carafoli E, Santella L (2001) NAADP
+
initiates the Ca
2+ response during fertilization of starfish oocytes. FASEB J 15:
2257–2267.
65. Chameau P, Van de Vrede Y, Fossier P, Baux G (2001) Ryanodine-, IP3-a n d
NAADP-dependent calcium stores control acetylcholine release. Pfleg Archiv
443: 289–296.
66. Brailoiu E, Miyamoto MD, Dun NJ (2001) Nicotinic acid adenine dinucleotide
phosphate enhances quantal neurosecretion at the frog neuromuscular junction:
possible action on synaptic vesicles in the releasable pool. Mol Pharmacol 60:
718–724.
67. Brailoiu E, Hoard JL, Filipeanu CM, Brailoiu GC, Dun SL, et al. (2005)
NAADP potentiates neurite outgrowth. J Biol Chem 280: 5646–5650.
68. Brailoiu E, Churamani D, Pandey V, Brailoiu GC, Tuluc F, et al. (2006)
Messenger-specific role for NAADP in neuronal differentiation. J Biol Chem
281: 15923–15928.
69. Terasaki M, Jaffe LA (1991) Organization of the sea urchin egg endoplasmic
reticulum and its reorganization at fertilization. J Cell Biol 114: 929–940.
70. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, et al. (2003) Multiple
sequence alignment with the Clustal series of programs. Nucleic Acids Res 31:
3497–3500.
71. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic
character of a protein. J Mol Biol 157: 105–132.
72. Berridge G, Cramer R, Galione A, Patel S (2002) Metabolism of the novel
Ca
2+-mobilizing messenger nicotinic acid-adenine dinucleotide phosphate via
a2 9-specific Ca
2+-dependent phosphatase. Biochem J 365: 295–301.
73. Dickinson GD, Patel S (2003) Modulation of NAADP receptors by K
+ ions:
Evidence for multiple NAADP receptor conformations. Biochem J 375:
805–812.
Luminal Messenger Synthesis?
PLoS ONE | www.plosone.org 13 August 2007 | Issue 8 | e797